Trademarkia Logo

Canada

C$
Trademark Search in Canada
4D LOGO DESIGN

View On IC.GC.CA

4D LOGO DESIGN
REGISTERED

on 4 Feb 2021

Last Applicant/ Owned by

4D PHARMA PLC

9 Bond Court,Leeds, England, LS1 2JZ

GB

Serial Number

1897419 filed on 4th May 2018

Registration Number

TMA1093112 registered on 4th Feb 2021

Registration expiry Date

4th Feb 2031

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO

ONTARIO

CA

M5H2T6

4D LOGO DESIGN

Trademark usage description

chemicals for use as pharmaceuticals; chemicals used in the manufacture of pharmaceuticals; raw proteins for use in pharmaceuticals. pharmaceuticals Read More

Vienna Information

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 17

Quadrilaterals containing one or more numeralsQuadrilatères contenant un ou plusieurs chiffres

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

Classification Information

Class [001]
Chemicals for use as pharmaceuticals; chemicals used in the manufacture of pharmaceuticals; raw proteins for use in pharmaceuticals.

Classification kind code

11

Class [005]
Pharmaceuticals and pharmaceuticals as live biotherapeutics for the treatment of brain injuries (namely strokes and ischemic events), central nervous system disorders (namely, multiple sclerosis, autism, obsessive compulsive disorder, depression, anxiety and neurodegenerative disorders, namely Parkinson's disease and Alzheimer's Disease), cancer, bowel disorders (namely, visceral hypersensitivity, diarrhea, constipation, bacterial infections, dysbiosis, irritable bowel syndrome and inflammatory bowel disorders, namely Crohn's disease and ulcerative colitis), lung disorders and diseases (namely, asthma, chronic obstructive pulmonary disease and acute respiratory distress syndrome), inflammatory diseases (namely arthritis) and autoimmune diseases; Live biotherapeutics and live biotherapeutic bacterial formulations for the treatment of brain injuries (namely strokes and ischemic events), central nervous system disorders (namely, multiple sclerosis, autism, obsessive compulsive disorder, depression, anxiety and neurodegenerative disorders, namely Parkinson's disease and Alzheimer's Disease), cancer, bowel disorders (namely, visceral hypersensitivity, diarrhea, constipation, bacterial infections, dysbiosis, irritable bowel syndrome and inflammatory bowel disorders, namely Crohn's disease and ulcerative colitis), lung disorders and diseases (namely, asthma, chronic obstructive pulmonary disease and acute respiratory distress syndrome), inflammatory diseases (namely arthritis) and autoimmune diseases; Preparations of microorganisms for the treatment of brain injuries (namely strokes and ischemic events), central nervous system disorders (namely, multiple sclerosis, autism, obsessive compulsive disorder, depression, anxiety and neurodegenerative disorders, namely Parkinson's disease and Alzheimer's Disease), cancer, bowel disorders (namely, visceral hypersensitivity, diarrhea, constipation, bacterial infections, dysbiosis, irritable bowel syndrome and inflammatory bowel disorders, namely Crohn's disease and ulcerative colitis), lung disorders and diseases (namely, asthma, chronic obstructive pulmonary disease and acute respiratory distress syndrome), inflammatory diseases (namely arthritis) and autoimmune diseases.

Classification kind code

11

Class [042]
Scientific research and development services in the field of pharmaceuticals, pharmaceuticals as live biotherapeutics, live biotherapeutics, live biotherapeutic bacterial formulations and preparations of microorganisms for the treatment of brain injuries (namely strokes and ischemic events), central nervous system disorders (namely, multiple sclerosis, autism, obsessive compulsive disorder, depression, anxiety and neurodegenerative disorders, namely Parkinson's disease and Alzheimer's Disease), cancer, bowel disorders (namely, visceral hypersensitivity, diarrhea, constipation, bacterial infections, dysbiosis, irritable bowel syndrome and inflammatory bowel disorders, namely Crohn's disease and ulcerative colitis), lung disorders and diseases (namely, asthma, chronic obstructive pulmonary disease and acute respiratory distress syndrome), inflammatory diseases (namely arthritis) and autoimmune diseases; microbiology research and development into live biotherapeutics.

Classification kind code

11

Mark Details

Serial Number

1897419

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 20th Jan 2021		Registration Pending
Submitted for opposition 42
on 28th Oct 2020		Advertised
Submitted for opposition 26
on 30th Sept 2020		Approved
Submitted for opposition 27
on 30th Sept 2020		Approval Notice Sent
Submitted for opposition 15
on 5th Aug 2020		Correspondence Created
Submitted for opposition 22
on 12th Nov 2019		Search Recorded
Submitted for opposition 20
on 12th Nov 2019		Examiner's First Report
Submitted for opposition 31
on 8th May 2018		Formalized
Submitted for opposition 30
on 4th May 2018		Filed
Submitted for opposition 1
on 4th May 2018		Created